SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

20 Oct 2014 16:18

RNS Number : 7983U
Orogen Gold PLC
20 October 2014
 



 

Orogen Gold plc

("Orogen" or the "Company")

 

Director/PDMR Shareholding

 

The Company announces that it has received notification that on 16 October 2014 McNolan Venture Limited, a company owned by Michael Nolan, a director of the Company, purchased 5,500,000 ordinary shares of 0.1p each in Orogen through the market at a price of 0.1p per share.

Following this transaction, which represents 0.15% of the issued share capital of the Company, Michael Nolan is interested in 110,110,907 shares in Orogen, representing 3.09% of the issued share capital of the Company.

 

Enquiries:

Orogen Gold Plc

+353 1662 8395

Ed Slowey, CEO

 

Alan Mooney, FD

 

 

WH Ireland Limited

(Nominated Adviser and Joint Broker)

+44 (0) 20 7220 1666

Tim Feather

 

James Bavister

 

 

Hume Capital Securities Plc

(Joint Broker)

+44 (0) 20 3693 1470

Jon Belliss

 

 

 

Walbrook

(Public Relations and Investor Relations)

+44 (0) 20 7933 8780

Paul Cornelius / Guy McDougall

 

 

 

 

About Orogen Gold

 

Orogen Gold plc is a UK public company quoted on the London Stock Exchange AIM market (ticker: ORE). The Company is focused on mineral exploration and development in Europe and is currently operating two gold exploration projects: a) at Mutsk in Armenia and b) at Deli Jovan in Serbia. The Mutsk gold project in Armenia was optioned by Orogen early in 2013 to follow-up reports of a new epithermal discovery within an established gold district. At Deli Jovan the historic high-grade gold mining camp was last in production prior to World War II and has been significantly under-explored in modern times.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSURAVRSVARUAA

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS